507 related articles for article (PubMed ID: 32660025)
1. Targeting the Intestinal Microbiota to Prevent Type 2 Diabetes and Enhance the Effect of Metformin on Glycaemia: A Randomised Controlled Pilot Study.
Palacios T; Vitetta L; Coulson S; Madigan CD; Lam YY; Manuel R; Briskey D; Hendy C; Kim JN; Ishoey T; Soto-Giron MJ; Schott EM; Toledo G; Caterson ID
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32660025
[TBL] [Abstract][Full Text] [Related]
2. The effect of a novel probiotic on metabolic biomarkers in adults with prediabetes and recently diagnosed type 2 diabetes mellitus: study protocol for a randomized controlled trial.
Palacios T; Vitetta L; Coulson S; Madigan CD; Denyer GS; Caterson ID
Trials; 2017 Jan; 18(1):7. PubMed ID: 28069054
[TBL] [Abstract][Full Text] [Related]
3. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986
[TBL] [Abstract][Full Text] [Related]
4. Restoring Insulin Secretion (RISE): design of studies of β-cell preservation in prediabetes and early type 2 diabetes across the life span.
RISE Consortium
Diabetes Care; 2014; 37(3):780-8. PubMed ID: 24194506
[TBL] [Abstract][Full Text] [Related]
5. Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut.
de la Cuesta-Zuluaga J; Mueller NT; Corrales-Agudelo V; Velásquez-Mejía EP; Carmona JA; Abad JM; Escobar JS
Diabetes Care; 2017 Jan; 40(1):54-62. PubMed ID: 27999002
[TBL] [Abstract][Full Text] [Related]
6. Increased circulating butyrate and ursodeoxycholate during probiotic intervention in humans with type 2 diabetes.
McMurdie PJ; Stoeva MK; Justice N; Nemchek M; Sieber CMK; Tyagi S; Gines J; Skennerton CT; Souza M; Kolterman O; Eid J
BMC Microbiol; 2022 Jan; 22(1):19. PubMed ID: 34996347
[TBL] [Abstract][Full Text] [Related]
7. Metformin exerts anti-obesity effect via gut microbiome modulation in prediabetics: A hypothesis.
Maniar K; Moideen A; Bhattacharyya R; Banerjee D
Med Hypotheses; 2017 Jul; 104():117-120. PubMed ID: 28673568
[TBL] [Abstract][Full Text] [Related]
8. Adjunctive Probio-X Treatment Enhances the Therapeutic Effect of a Conventional Drug in Managing Type 2 Diabetes Mellitus by Promoting Short-Chain Fatty Acid-Producing Bacteria and Bile Acid Pathways.
Chen Y; Shen X; Ma T; Yu X; Kwok LY; Li Y; Sun Z; Li D; Zhang H
mSystems; 2023 Feb; 8(1):e0130022. PubMed ID: 36688679
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of serum zonulin level in prediabetic patients.
Saitogullari N; Sayili U; Altunoglu E; Uzun H
Ann Endocrinol (Paris); 2021 Feb; 82(1):1-7. PubMed ID: 33278377
[TBL] [Abstract][Full Text] [Related]
10. Effect of lifestyle interventions with or without metformin therapy on serum levels of osteoprotegerin and receptor activator of nuclear factor kappa B ligand in patients with prediabetes.
Arslan MS; Tutal E; Sahin M; Karakose M; Ucan B; Ozturk G; Cakal E; Biyikli Gencturk Z; Ozbek M; Delibasi T
Endocrine; 2017 Feb; 55(2):410-415. PubMed ID: 27743302
[TBL] [Abstract][Full Text] [Related]
11.
Oh MR; Jang HY; Lee SY; Jung SJ; Chae SW; Lee SO; Park BH
Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371847
[TBL] [Abstract][Full Text] [Related]
12. Metformin with Versus without Concomitant Probiotic Therapy in Newly Diagnosed Patients with Type 2 Diabetes or Prediabetes: A Comparative Analysis in Relation to Glycemic Control, Gastrointestinal Side Effects, and Treatment Compliance.
Şahin K; Şahintürk Y; Köker G; Özçelik Köker G; Bostan F; Kök M; Uyar S; Çekin AH
Turk J Gastroenterol; 2022 Nov; 33(11):925-933. PubMed ID: 36098362
[TBL] [Abstract][Full Text] [Related]
13. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
Freemark M; Bursey D
Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
[TBL] [Abstract][Full Text] [Related]
14. Results of a placebo-controlled study of the metabolic effects of the addition of metformin to sulfonylurea-treated patients. Evidence for a central role of adipose tissue.
Abbasi F; Kamath V; Rizvi AA; Carantoni M; Chen YD; Reaven GM
Diabetes Care; 1997 Dec; 20(12):1863-9. PubMed ID: 9405908
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiota modulation as a promising therapy with metformin in rats with non-alcoholic steatohepatitis: Role of LPS/TLR4 and autophagy pathways.
Ahmed LA; Salem MB; Seif El-Din SH; El-Lakkany NM; Ahmed HO; Nasr SM; Hammam OA; Botros SS; Saleh S
Eur J Pharmacol; 2020 Nov; 887():173461. PubMed ID: 32758573
[TBL] [Abstract][Full Text] [Related]
16. Inadequate Vitamin C Status in Prediabetes and Type 2 Diabetes Mellitus: Associations with Glycaemic Control, Obesity, and Smoking.
Wilson R; Willis J; Gearry R; Skidmore P; Fleming E; Frampton C; Carr A
Nutrients; 2017 Sep; 9(9):. PubMed ID: 28891932
[TBL] [Abstract][Full Text] [Related]
17. Addition of a Gastrointestinal Microbiome Modulator to Metformin Improves Metformin Tolerance and Fasting Glucose Levels.
Burton JH; Johnson M; Johnson J; Hsia DS; Greenway FL; Heiman ML
J Diabetes Sci Technol; 2015 Jul; 9(4):808-14. PubMed ID: 25802471
[TBL] [Abstract][Full Text] [Related]
18. Additional Effect of Dietary Fiber in Patients with Type 2 Diabetes Mellitus Using Metformin and Sulfonylurea: An Open-Label, Pilot Trial.
Lee SE; Choi Y; Jun JE; Lee YB; Jin SM; Hur KY; Ko GP; Lee MK
Diabetes Metab J; 2019 Aug; 43(4):422-431. PubMed ID: 31237126
[TBL] [Abstract][Full Text] [Related]
19. Metformin Use in Prediabetes Among U.S. Adults, 2005-2012.
Tseng E; Yeh HC; Maruthur NM
Diabetes Care; 2017 Jul; 40(7):887-893. PubMed ID: 28373205
[TBL] [Abstract][Full Text] [Related]
20. Effect of bromocriptine-QR therapy on glycemic control in subjects with type 2 diabetes mellitus whose dysglycemia is inadequately controlled on insulin.
Chamarthi B; Cincotta AH
Postgrad Med; 2017 May; 129(4):446-455. PubMed ID: 28374645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
